What has COVID-19 cost your pharmacy?

We are living in unprecedented times. Hospitals must quickly control costs and prioritize initiatives while dealing with the impact of the global pandemic.

The Vizient® Drug Price Forecast, the industry’s leading report on pharmaceutical trends, provides 18-month drug price projections and analytical insights, and discusses therapy developments and issues that impact health system pharmacies. Access this forecast to learn more about the impact of COVID-19 on the health care landscape, including:

  • Current drug spend and price projections for the leading drugs used to manage COVID-19 patients
  • Brand and generic drugs that top the charts in terms of price increases and total spend
  • Impact on classes of trade and key therapeutic areas including acute care, specialty pharmacy, oncology, pediatrics and more
  • Strategies for improving the supply of essential medications and controlling costs
  • Recommended action steps to manage further disruption and plan for the future

Get the 2020 Drug Price Forecast

"Our pharmacy relies on the pediatric price inflation rate in the Drug Price Forecast."

Casey Dugan, Pharm.D., MBA
VP, Pharmacy Services
Children's Hospital Colorado

Preview of insights

Although COVID-19 has reinforced the relevance of high-quality critical care, it has also caused a significant amount of disruption in the non-acute setting.

Acute care
The COVID-19 outbreak pushed the acute care setting to capacity in managing critical patients’ access to essential medications and urgent, lifesaving interventions.

Non-acute care
As communities implemented shelter-in-place policies in response to COVID-19, home infusion therapy increased while vaccines, lab testing and other non-acute services decreased significantly.

Learn more

Connect with us to learn how our pharmacy experts can help guide your recovery and future planning efforts